Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CDXS
#3699
Codexis, Inc. - Common Stock
1.5
9
USD
-0.04%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-4.22%
Monthly Change
+6.71%
6 month change
+59.00%
Year Change
-41.11%
Previous Close
1.6
6
Open
1.5
9
Low
1.5
9
High
1.5
9
Volume
45
Markets
US Stock Market
Healthcare
Biotechnology
CDXS
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
64.4 M
65.16 M
65.95 M
70.3 M
82.84 M
90.87 M
109.51 M
Valuation ratios
Enterprise value
1.26 B
1.92 B
193.99 M
154.23 M
404.77 M
137.43 M
192.86 M
Price to earnings ratio
—
-94.76
-9.16
-2.79
-5.36
-3.26
-5.11
Price to sales ratio
—
19.27
2.2
3.03
5.9
2.02
1.87
Price to cash flow ratio
—
-141.52
27.04
-4.04
-7.09
-7.33
-15.5
Price to book ratio
—
12.28
2.11
2.45
5.23
2.81
0.89
Enterprise value to EBITDA ratio
-57.6
-98.61
-6.58
-2.47
-7.56
-3.77
-8.59
Profitability ratios
Return on assets %
-0.11
-0.09
-0.13
-0.56
-0.44
-0.3
-0.1
Return on equity %
-0.14
-0.13
-0.23
-0.88
-0.98
-0.87
-0.36
Return on invested capital %
-173.52
-103.84
-119.26
-292.06
-347.28
-232.21
-71.97
Gross margin %
80.04
78.47
72.52
81.74
72.55
86.73
76.45
Operating margin %
-34.64
-21.67
-25.17
-97.04
-98.61
-59.3
-75.29
EBITDA margin %
-31.59
-18.59
-21.26
-89.18
-90.27
-51.84
-67.17
Net margin %
-34.77
-20.31
-24.24
-108.69
-109.99
-62.47
-80.49
Liquidity ratios
Quick ratio
7.34
4.82
3.28
2.53
4.1
3.75
2.99
Current ratio
7.38
4.85
3.32
2.61
4.18
3.82
3.06
Inventory turnover
20.59
20.91
23.85
5.43
7.26
5.14
1.95
Asset turnover
0.37
0.45
0.56
0.36
0.42
0.48
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
0.19
0.27
0.34
Debt to equity ratio
—
—
—
—
0.43
0.79
1.24
Long term debt to total assets ratio
—
—
—
—
0.19
0.27
0.34
Long term debt to total equity ratio
—
—
—
—
0.43
0.79
1.24
Per share metrics
Operating cash flow per share
—
-0.22
0.17
-0.77
-0.67
-0.22
-0.11
EBIT per share
—
-0.35
-0.53
-1
-0.8
-0.48
-0.3
EBITDA per share
—
-0.3
-0.45
-0.92
-0.73
-0.42
-0.24
Total debt per share
—
—
—
—
0.39
0.46
0.45
Cash per share
—
1.81
1.74
0.96
1
0.9
0.6
Net current asset value per share
—
2.51
2.49
1.37
1.35
1.11
0.79
Tangible book value per share
—
2.55
2.22
1.27
0.91
0.55
0.33
Working capital per share
—
1.99
1.74
0.85
1.02
0.82
0.53
Book value per share
—
2.55
2.22
1.27
0.91
0.58
0.36
News
Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Beat Estimates
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates
AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates
Codexis: ECO Synthesis And Runway Reset Warrant An Upgrade (NASDAQ:CDXS)
Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript
Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS)
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal